About the role
We are seeking an innovative, creative, and detail-oriented Quality Control Analyst to join our team in Bridgewater, New Jersey. This position will be responsible for routine and non-routine QC testing according to Standard Operating Procedures (SOPs). This role supports the day-to-day operations within the Quality Control group via execution of analytical testing. This includes but is not limited to in-process testing, lot release testing, stability testing, and raw material testing. All activities are all performed in accordance with cGMP guidelines and are supported by departmental and inter-departmental policies and standard operating procedures.
This role will be a hands-on resource reporting to the Senior Director, Quality Control Bioanalytics.
Candidates should enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows.
Aplyr's read
Cellares is revolutionizing cell therapy manufacturing through automation, attracting professionals keen on innovation in biotechnology and operational efficiency.
What's promising
- •Cellares focuses on automating cell therapy, addressing a critical need for efficiency in biotechnology.
- •The company offers diverse roles, indicating growth and a dynamic work environment.
- •Cellares is committed to improving accessibility in cell therapy, a rapidly growing field.
What to watch
- •The niche focus on cell therapy may limit broader career opportunities.
- •As a biotech company, Cellares faces regulatory challenges that can impact timelines.
- •Limited public information about financial stability and long-term viability.
Why Cellares
- •Cellares' automation focus sets it apart in the cell therapy manufacturing sector.
- •The company integrates advanced technology roles, like Enterprise AI, into biotech.
- •Cellares' commitment to accessibility in cell therapy is a distinctive mission.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Cellares
Cellares is a biotechnology company focused on automating cell therapy manufacturing to improve efficiency and accessibility.